Navigation Links
MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
Date:6/9/2008

ORCHARD PARK, N.Y., June 9 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (Amex: BUF) today announced it has received approval from the U.S. Food and Drug Administration Center for Veterinary Medicine to market Petrem(TM) (Sevoflurane) inhalation anesthetic. This week they have initiated their US product launch to the veterinary market.

About the Company

MINRAD International, Inc. is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines. The real-time image guidance products facilitate minimally invasive surgery especially for pain management and have broad applications in orthopedics, neurosurgery, and interventional radiology. These devices enable medical professionals to improve the accuracy of interventional procedures and reduce radiation exposure. MINRAD International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. Additional information can be found at the company's website, http://www.minrad.com.

The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Factors that may cause actual results to differ materially from those expressed or implied by its forward-looking statements include, but are not limited to, Minrad International's limited operating history and business development associated with being a growth stage company; its dependence on key personnel; its need to attract and retain technical and managerial personnel; its ability to execute its business strategy; the intense competition it faces; its ability to protect its intellectual property and proprietary technologies; its exposure to product liability claims resulting from the use of its products; general economic and capital market conditions; financial conditions of its customers and their perception of its financial condition relative to that of its competitors; as well as those risks described under the heading "Risk Factors" of Minrad International's Form 10-KSB-A, filed with the Securities and Exchange Commission on April 21, 2008.. Although Minrad International, Inc. believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.

CONTACT:

Charles R. Trego, Jr.

Executive Vice President and CFO

E-mail: ctrego@minrad.com


'/>"/>
SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MINRAD International, Inc. Announces 2007 Financial Results
2. MINRAD International, Inc. to Discuss 2007 Fourth Quarter and Full Year Financial Results on Monday, March 31, 2008
3. MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
4. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
5. Jury Rules in Favor of Glycoproducts International, Inc.
6. Lockheed Martin Completes Acquisition of Eagle Group International, LLC
7. Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington
8. China Yingxia International, Inc. Reports First Quarter 2008 Results
9. Natural Alternatives International, Inc. Announces Third Quarter Results
10. China Yingxia International, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
11. CalbaTech, Inc. Officially Changes Name to LifeStem International, Inc.; Lists New Symbol (LSTM) and Launches New Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has published a ... an astounding statement when he says that the entire Bible was written for the ... times so plainly that anyone should be able to see the time period. He ...
(Date:2/24/2017)... VA (PRWEB) , ... February 24, 2017 , ... The ... winners for excellence in radiology marketing programs at the annual Building Better Radiology ... Worthington Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given out ...
(Date:2/24/2017)... MI (PRWEB) , ... February 24, 2017 , ... ... in Charlevoix, once again hosted their Military Wedding Giveaway, with the winning ... hosted by Castle Farms with services generously donated from local vendors: A Matter ...
(Date:2/23/2017)... Boulder, CO (PRWEB) , ... February 23, 2017 , ... ... to announce the winner of the 2016 National Education Policy Center Bunkum Award. We ... report reviewed in 2016. , This year’s Bunkum winner is the Center for American ...
(Date:2/23/2017)... ... , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased to announce KLS ... longtime supporter of the event. , "We are pleased that KLS Martin is joining ... 2017 ACPA President. "KLS Martin has a long track record of support of the ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical ... products for the urology market, will release financial results ... 31, 2016 before the market open on Thursday, March ... a conference call and webcast to discuss its financial ... at 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... , 23. Februar 2017 Im Rahmen ... eine nationale Wirtschaftszone in der südwestlichen chinesischen Provinz Guizhou, 2017 ... Errichtung einer Innovationsplattform aktiv an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. ... Continue Reading ... ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... leading the discovery and development of innovative medicines targeting ... full year 2016 financial results on Thursday, March 2, ... host a conference call and webcast on March 2, ... quarter and full year 2016 financial results and provide ...
Breaking Medicine Technology: